http://www.fda.gov/medical-devices/medical-device-recalls/endoscopic-vessel-harvesting-system-recall-getinge-and-maquet-cardiovascular-remove-vasoview-hemopro

FDA Approves First Gene Therapy for Treatment of Aromatic L-amino Acid Decarboxylase Deficiency
http://www.fda.gov/news-events/press-announcements/fda-approves-first-gene-therapy-treatment-aromatic-l-amino-acid-decarboxylase-deficiency

FDA Roundup: November 8, 2024
http://www.fda.gov/news-events/press-announcements/fda-roundup-november-8-2024

FDA Proposes Ending Use of Oral Phenylephrine as OTC Monograph Nasal Decongestant Active Ingredient After Extensive Review
http://www.fda.gov/news-events/press-announcements/fda-proposes-ending-use-oral-phenylephrine-otc-monograph-nasal-decongestant-active-ingredient-after

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/vitalityvita-issues-voluntary-nationwide-recall-vitalityxtra-and-peakmax-capsules-due-presence

FDA Roundup: November 5, 2024
http://www.fda.gov/news-events/press-announcements/fda-roundup-november-5-2024

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/boulla-llc-issues-voluntary-nationwide-recall-zoommax-and-zapmax-capsules-due-presence-undeclared

FDA Roundup: November 1, 2024
http://www.fda.gov/news-events/press-announcements/fda-roundup-november-1-2024

http://www.fda.gov/medical-devices/medical-device-recalls/ipv-therapy-device-recall-percussionaire-removes-certain-phasitron-5-breathing-circuits-due-risk

http://www.fda.gov/medical-devices/medical-device-recalls/incubatorwarmer-correction-ge-healthcare-updates-use-instructions-giraffe-omnibed-and-giraffe